Chuck Bramlage

Chuck Bramlage is currently a Board of Directors member at Clarametyx Biosciences, Inc. Chuck was previously the President at Yamo Pharmaceuticals, Covidien, and Valeant Pharmaceuticals. Their first VP position was at GlaxoSmithKline where they worked from 1983 to 2001.

Chuck Bramlage has a BS in Marketing from The Ohio State University Fisher College of Business and an MBA in Finance from the University of Dayton.